A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis

详细信息	查看全文 | 推荐本文 |

• 作者：Reema Gupta^a ; Pramod K. Kushawaha^a ; Chandra Dev Pati Tripathi^a ; Shyam Sundar^b ; Anuradha Dube^a ; ^{anuradha_dube@rediffmail.com} ; ^{anuradha_dube@hotmail.com}
• 关键词：Leishmania donovani ; Recombinant p45 ; Methionine aminopeptidase ; Immunogenicity ; T-cell response ; Cured Leishmania hamsters ; Cured Leishmania patients and endemic contacts ; Prophylactic potential
• 刊名：International Journal for Parasitology
• 出版年：2012
• 期刊代码：124_00207519
• 类别：med
• 出版时间：1 May, 2012
• 卷：42
• 期：5
• 页码：429-435
• 文件大小：941 K

摘要

The development of a vaccine against visceral leishmaniasis (VL) conferring long-lasting immunity remains a challenge. Identification and proteomic characterization of parasite proteins led to the detection of p45, a member of the methionine aminopeptidase family. To our knowledge the present study is the first known report that describes the molecular and immunological characterization of p45. Recombinant Leishmania donovani p45 (rLdp45) induced cellular responses in cured hamsters and generated Th1-type cytokines from peripheral blood mononuclear cells of cured/endemic VL patients. Immunization with rLdp45 exerted considerable prophylactic efficacy (鈭?5%) supported by an increase in mRNA expression of iNOS, IFN-纬, TNF-伪 and IL-12 and decrease in TGF-尾 and IL-4, indicating its potential as a vaccine candidate against VL.